Citation tools
"Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance." Drug Metabolism and Disposition
46.9
(2018):
1285-1303.
Web. 19 April. 2024.